Royalty Pharma Plc

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: GB00BMVP7Y09

USD

45.97

0.13 (0.28%)

Mar 10

NAS

View all stocks in this country

Company CV

About Royalty Pharma Plc

stock-summary

Royalty Pharma Plc

Pharmaceuticals & Biotechnology

Royalty Pharma plc is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in approximately 45 commercial products and four development-stage product candidates.

Company Coordinates

Company Details

110 East 59th Street , NEW YORK NY : 10022

stock-summary

Tel: 1 212 8830200

stock-summary

https://www.royaltypharma.com

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Domestic Funds

Held in 95 Schemes (30.68%)

Foreign Institutions

Held by 291 Foreign Institutions (27.43%)

Strategic Entities with highest holding

Highest Public shareholder

Board of Directors

Management

Designation

Mr. Pablo Legorreta

Chairman of the Board, Chief Executive Officer

Mr. Christopher Hite

Vice Chairman of the Board, Executive Vice President

Mr. M. Germano Giuliani

Director

Mr. Rory Riggs

Director

Dr. Bonnie Bassler

Independent Director

Dr. Errol De Souza

Independent Director

Ms. Catherine Engelbert

Independent Director

Stock DNA

Revenue and Profits:

Net Sales:

622 Million

(Quarterly Results - Dec 2025)

Net Profit:

356 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 26,030 Million (Mid Cap)

P/E

13.00

Industry P/E

NA

Dividend Yield

2.58%

Debt Equity

1.28

Return on Equity

20.08%

Price to Book

4.02